260 related articles for article (PubMed ID: 16956591)
21. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
van Vliet SA; Blezer EL; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
Brain Res; 2008 Jan; 1189():219-28. PubMed ID: 18076869
[TBL] [Abstract][Full Text] [Related]
22. Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity-induced by 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) in mice.
Abdel-Wahab MH
J Biochem Mol Toxicol; 2005; 19(1):32-41. PubMed ID: 15736157
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice.
Rajeswari A; Sabesan M
Inflammopharmacology; 2008 Apr; 16(2):96-9. PubMed ID: 18408903
[TBL] [Abstract][Full Text] [Related]
24. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
Liu LX; Chen WF; Xie JX; Wong MS
Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
[TBL] [Abstract][Full Text] [Related]
26. Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
Cleren C; Starkov AA; Calingasan NY; Lorenzo BJ; Chen J; Beal MF
Neurobiol Dis; 2005 Dec; 20(3):701-8. PubMed ID: 16126396
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons.
McKinley ET; Baranowski TC; Blavo DO; Cato C; Doan TN; Rubinstein AL
Brain Res Mol Brain Res; 2005 Nov; 141(2):128-37. PubMed ID: 16209898
[TBL] [Abstract][Full Text] [Related]
28. Ebselen prevents noise-induced excitotoxicity and temporary threshold shift.
Yamasoba T; Pourbakht A; Sakamoto T; Suzuki M
Neurosci Lett; 2005 Jun; 380(3):234-8. PubMed ID: 15862892
[TBL] [Abstract][Full Text] [Related]
29. Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain.
Burger ME; Fachinetto R; Zeni G; Rocha JB
Pharmacol Biochem Behav; 2005 Jul; 81(3):608-15. PubMed ID: 15953628
[TBL] [Abstract][Full Text] [Related]
30. Lithium and oxidative stress lessons from the MPTP model of Parkinson's disease.
Arraf Z; Amit T; Youdim MB; Farah R
Neurosci Lett; 2012 May; 516(1):57-61. PubMed ID: 22480690
[TBL] [Abstract][Full Text] [Related]
31. Toki-to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice.
Sakai R; Irie Y; Murata T; Ishige A; Anjiki N; Watanabe K
Phytother Res; 2007 Sep; 21(9):868-73. PubMed ID: 17486689
[TBL] [Abstract][Full Text] [Related]
32. Protective effects on neuronal cells of mouse afforded by ebselen against oxidative stress at multiple steps.
Satoh T; Ishige K; Sagara Y
Neurosci Lett; 2004 Nov; 371(1):1-5. PubMed ID: 15500956
[TBL] [Abstract][Full Text] [Related]
33. Effects of preconditioning with ebselen on glutathione metabolism and stress protein expression.
Hoshida S; Aoki K; Nishida M; Yamashita N; Igarashi J; Hori M; Kuzuya T; Tada M
J Pharmacol Exp Ther; 1997 Jun; 281(3):1471-5. PubMed ID: 9190885
[TBL] [Abstract][Full Text] [Related]
34. Bak Foong protects dopaminergic neurons against MPTP-induced neurotoxicity by its anti-apoptotic activity.
Liu B; Xie JX; Tsang LL; Rowlands DK; Ho LS; Gou YL; Chung YW; Chan HC
Cell Biol Int; 2008 Jan; 32(1):86-92. PubMed ID: 17920944
[TBL] [Abstract][Full Text] [Related]
35. Ebselen decreases oxygen free radical production and iron concentrations in the hearts of chronically iron-overloaded mice.
Davis MT; Bartfay WJ
Biol Res Nurs; 2004 Jul; 6(1):37-45. PubMed ID: 15186706
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
Shin JY; Park HJ; Ahn YH; Lee PH
J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
[TBL] [Abstract][Full Text] [Related]
37. In vivo modulation of the Parkinsonian phenotype by Nrf2.
Burton NC; Kensler TW; Guilarte TR
Neurotoxicology; 2006 Dec; 27(6):1094-100. PubMed ID: 16959318
[TBL] [Abstract][Full Text] [Related]
38. Amiloride is neuroprotective in an MPTP model of Parkinson's disease.
Arias RL; Sung ML; Vasylyev D; Zhang MY; Albinson K; Kubek K; Kagan N; Beyer C; Lin Q; Dwyer JM; Zaleska MM; Bowlby MR; Dunlop J; Monaghan M
Neurobiol Dis; 2008 Sep; 31(3):334-41. PubMed ID: 18606547
[TBL] [Abstract][Full Text] [Related]
39. Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice.
Muroyama A; Inaka M; Matsushima H; Sugino H; Marunaka Y; Mitsumoto Y
Neurosci Res; 2009 Jan; 63(1):72-5. PubMed ID: 18977253
[TBL] [Abstract][Full Text] [Related]
40. A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease.
Bahat-Stroomza M; Gilgun-Sherki Y; Offen D; Panet H; Saada A; Krool-Galron N; Barzilai A; Atlas D; Melamed E
Eur J Neurosci; 2005 Feb; 21(3):637-46. PubMed ID: 15733082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
